Abstract
Endothelial cell proliferation and migration is initiated by growth factors including FGF and VEGF that bind to specific transmembrane receptor tyrosine kinases. Mechanisms that regulate in vivo expression of fibroblast growth factor receptors (FGFR) and vascular endothelial growth factor receptors (VEGFR) are not well understood. Since it is well known that different matrices influence the proliferation and migration of endothelial cells in culture, we hypothesized that changes in the extracellular matrix environment can regulate growth factor receptors on endothelial cells. We cultured human microvascular endothelial cells on different matrices (vitronectin, laminin, fibronectin, fibrin, and collagen IV) and examined for the presence of growth factor receptors (FGFR-1, FGFR-2, VEGFR-1, and VEGFR-2). We show that vitronectin increased the presence of all four growth factor receptors and most notably, VEGFR-1. In contrast, fibrin decreased all four receptors, especially FGFR-1 and FGFR-2. Inhibiting phosphotyrosine signaling abolished immunostaining for all four receptors, regardless of the matrix, but was not dependent on activating the Fyn-Shc pathway. Cells plated on vitronectin in the presence of blocking antibodies to integrins αvβ3 and αvβ5 similarly decreased presence of these growth factor receptors. Our data suggests a possible mechanism of how matrix-integrin interactions regulate endothelial cell responsiveness to growth factors and anchorage-dependent cell growth.
Similar content being viewed by others
References
Peacock EEJ: Wound repair. WB Saunders, Philadelphia, 1984
Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931–10934, 1992
Gibran NS, Isik FF, Heimbach DM, Gordon D: Basic fibroblast growth factor in the early human burn wound. J Surg Res 56: 226–234, 1994
Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13: 9–22, 1999
Peters KG, De VC, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915–8919, 1993
Risau W: Mechanisms of angiogenesis. Nature 386: 671–674, 1997
Hanahan D: Signaling vascular morphogenesis and maintenance. Science 277: 48–50, 1997
Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 87: 1153–1155, 1996
Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453–481, 1993
Vlodavsky I, Korner G, Ishai MR, Bashkin P, Bar SR, Fuks Z: Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9: 203–226, 1990
Takenaka H, Kishimoto S, Tooyama I, Kimura H, Yasuno H: Protein expression of fibroblast growth factor receptor-1 in keratinocytes during wound healing in rat skin. J Invest Dermatol 109: 108–112, 1997
Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT: Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 89: 6896–6900, 1992
Underwood PA, Bennett FA: The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells. Exp Cell Res 205: 311–319, 1993
Madri JA, Williams SK: Capillary endothelial cell cultures: Phenotypic modulation by matrix components. J Cell Biol 97: 153–165, 1983
Form DM, Pratt BM, Madri JA: Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab Invest 55: 521–530, 1986
Isik FF, Gibran NS, Jang YC, Sandell L, Schwartz SM: Vitronectin decreases microvascular endothelial cell apoptosis. J Cell Physiol 175: 149–155, 1998
Zimrin AB, Villeponteau B, Maciag T: Models of in vitro angiogenesis: Endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem Biophys Res Commun 213: 630–638, 1995
Ruoslahti E, Pierschbacher MD: New perspectives in cell adhesion: RGD and integrins. Science 238: 491–497, 1987
Hynes RO: Integrins: A family of cell surface receptors. Cell 48: 549–554, 1987
Swerlick RA, Brown EJ, Xu Y, Lee KH, Manos S, Lawley TJ: Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells. J Invest Dermatol 99: 715–722, 1992
Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM: Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58: 945–953, 1989
Cheng YF, Kramer RH: Human microvascular endothelial cells express integrin-related complexes that mediate adhesion to the extracellular matrix. J Cell Physiol 139: 275–286, 1989
Suehiro K, Gailit J, Plow EF: Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells. J Biol Chem 272: 5360–5366, 1997
Felding-Habermann B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 5: 864–868, 1993
Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT: Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14: 1680–1688, 1994
Giancotti FG, Ruoslahti E: Integrin signaling. Science 285: 1028–1032, 1999
Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG: The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87: 733–743, 1996
Wary KK, Mariotti A, Zurzolo C, Giancotti FG: A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625–634, 1998
Jerdan J, Michels R, Glaser B: Extracellular matrix of newly forming vessels - an immunohistochemical study. Microvasc Res 42: 255–265, 1991
Nicosia RF, Madri JA: The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol 128: 78–90, 1987
Clark RA, Tonnesen MG, Gailit J, Cheresh DA: Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. Am J Pathol 148: 1407–1421, 1996
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Jin-no K, Tanimizu M, Hyodo I, Kurimoto F, Yamashita T: Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease. J Gastroenterol 32: 119–121, 1997
Battegay EJ: Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73: 333–346, 1995
Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845–848, 1992
Antoniades HN, Galanopoulos T, Neville-Golden J, Kiritsy CP, Lynch SE: Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci USA 88: 565–569, 1991
D'Amore PA: Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev 9: 227–238, 1990
Fambrough D, McClure K, Kazlauskas A, Lander ES: Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes (see comments). Cell 97: 727–741, 1999
Ortega N, L'Faqihi FE, Plouet J: Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. Biol Cell 90: 381–390, 1998
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157–1164, 1994
Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569–571, 1994
Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500–1502, 1995
Charo IF, Nannizzi L, Smith JW, Cheresh DA: The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol: 1990
Felding H-B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 5: 864–868, 1993
Liang P, Pardee A: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967–971, 1992
Olander JV, Bremer ME, Marasa JC, Feder J: Fibrin-enhanced endothelial cell organization. J Cell Physiol 125: 1–9, 1985
Bhattacharya S, Fu C, Bhattacharya J, Greenberg S: Soluble ligands of the alpha v beta 3 integrin mediate enhanced tyrosine phosphorylation of multiple proteins in adherent bovine pulmonary artery endothelial cells. J Biol Chem 270: 16781–16787, 1995
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsou, R., Isik, F.F. Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem 224, 81–89 (2001). https://doi.org/10.1023/A:1011947301849
Issue Date:
DOI: https://doi.org/10.1023/A:1011947301849